Positive inotropic agents in myocardial ischemia-reperfusion injury: A benefit/risk analysis

Anesthesiology

Volumn 118, Issue 6, 2013, Pages 1460-1465

  Fellahi, Jean Luc ^a   Fischer, Marc Olivier ^a   Daccache, Georges ^a   Gerard, Jean Louis ^a   Hanouz, Jean Luc ^b  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b CHU CÔTE DE NACRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CARDIAC GLYCOSIDE; CATECHOLAMINE; DOBUTAMINE; DOPAMINE; DOPEXAMINE; INOTROPIC AGENT; ISOPRENALINE; LEVOSIMENDAN; NORADRENALIN; PHOSPHODIESTERASE III INHIBITOR;

ACUTE CORONARY SYNDROME; ARTICLE; CALCIUM CELL LEVEL; CARDIOPULMONARY BYPASS; CELL DEATH; EVIDENCE BASED MEDICINE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HEART RIGHT VENTRICLE FAILURE; HEART SURGERY; HUMAN; OXYGEN CONSUMPTION; OXYGEN SUPPLY; PRIORITY JOURNAL; REPERFUSION INJURY; TRANSLUMINAL CORONARY ANGIOPLASTY; VASODILATATION;

CARDIOTONIC AGENTS; HUMANS; MYOCARDIAL REPERFUSION INJURY; RISK ASSESSMENT;

EID: 84878628423     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31828f4fc3     Document Type: Article

References (32)

1. Hasenfuss G, Holubarsch C, Heiss HW, Meinertz T, Bonzel T, Wais U, Lehmann M, Just H: Myocardial energetics in patients with dilated cardiomyopathy. Influence of nitroprusside and enoximone. Circulation 1989; 80:51-64
2. Hasenfuss G, Teerlink JR: Cardiac inotropes: Current agents and future directions. Eur Heart J 2011; 32:1838-45
3. Bastien O, Vallet B; French Study Group AGIR: French multicentre survey on the use of inotropes after cardiac surgery. Crit Care 2005; 9:241-2
4. Schwinn DA: Cardiac pharmacology, Cardiac Anesthesia: Principles and Clinical Practice. Edited by Estafanous FG, Barash PG, Reves JG. Philadelphia, JB Lippincott, 1994, pp 21-60
5. Brodde OE, Zerkowski HR, Borst HG, Maier W, Michel MC: Drug- and disease-induced changes of human cardiac beta 1- and beta 2-Adrenoceptors. Eur Heart J 1989; 10(suppl B):38-44
6. Port JD, Gilbert EM, Larrabee P, Mealey P, Volkman K, Ginsburg R, Hershberger RE, Murray J, Bristow MR: Neurotransmitter depletion compromises the ability of indirect- acting amines to provide inotropic support in the failing human heart. Circulation 1990; 81:929-38
7. Toller WG, Stranz C: Levosimendan, a new inotropic and vasodilator agent. Anesthesiology 2006; 104:556-69
8. Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L; Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study: Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): A randomised double-blind trial. Lancet 2002; 360:196-202
9. Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ, Thakkar R, Padley RJ, Põder P, Kivikko M; SURVIVE Investigators: Levosimendan vs dobutamine for patients with acute decompensated heart failure: The SURVIVE Randomized Trial. JAMA 2007; 297:1883-91
10. Moiseyev VS, Põder P, Andrejevs N, Ruda MY, Golikov AP, Lazebnik LB, Kobalava ZD, Lehtonen LA, Laine T, Nieminen MS, Lie KI; RUSSLAN Study Investigators: Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J 2002; 23:1422-32
11. Landoni G, Biondi-Zoccai G, Greco M, Greco T, Bignami E, Morelli A, Guarracino F, Zangrillo A: Effects of levosimendan on mortality and hospitalization. A meta-Analysis of randomized controlled studies. Crit Care Med 2012; 40:634-46
12. Butterworth JF IV, Legault C, Royster RL, Hammon JW Jr: Factors that predict the use of positive inotropic drug support after cardiac valve surgery. Anesth Analg 1998; 86:461-7
13. Kastrup M, Markewitz A, Spies C, Carl M, Erb J, Grosse J, Schirmer U: Current practice of hemodynamic monitoring and vasopressor and inotropic therapy in post-operative cardiac surgery patients in Germany: Results from a postal survey. Acta Anaesthesiol Scand 2007; 51:347-58
14. Kallmeyer IJ, Collard CD, Fox JA, Body SC, Shernan SK: The safety of intraoperative transesophageal echocardiography: A case series of 7200 cardiac surgical patients. Anesth Analg 2001; 92:1126-30
15. Gillies M, Bellomo R, Doolan L, Buxton B: Bench-to-bedside review: Inotropic drug therapy after adult cardiac surgery - a systematic literature review. Crit Care 2005; 9:266-79
16. Silver IA, Erecińska M: Ion homeostasis in rat brain in vivo: Intra- and extracellular [Ca2+] and [H+] in the hippocampus during recovery from short-term, transient ischemia. J Cereb Blood Flow Metab 1992; 12:759-72
17. Scoote M, Williams AJ: Myocardial calcium signalling and arrhythmia pathogenesis. Biochem Biophys Res Commun 2004; 322:1286-309
18. Mebazaa A, Pitsis AA, Rudiger A, Toller W, Longrois D, Ricksten SE, Bobek I, De Hert S, Wieselthaler G, Schirmer U, von Segesser LK, Sander M, Poldermans D, Ranucci M, Karpati PC, Wouters P, Seeberger M, Schmid ER, Weder W, Follath F: Clinical review: Practical recommendations on the management of perioperative heart failure in cardiac surgery. Crit Care 2010; 14:201
19. Kabas JS, Spratt JA, Davis JW, Rankin JS, Glower DD: The effects of dopamine on myocardial functional recovery after reversible ischemic injury. J Thorac Cardiovasc Surg 1990; 100:715-23
20. Fowler MB, Alderman EL, Oesterle SN, Derby G, Daughters GT, Stinson EB: Dobutamine and dopamine after cardiac surgery: Greater augmentation of myocardial blood flow with dobutamine. Circulation 1984; 7(suppl I):I103-11
21. Chappell D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm M: A rational approach to perioperative fluid management. Anesthesiology 2008; 109:723-40
22. St André AC, DelRossi A: Hemodynamic management of patients in the first 24 hours after cardiac surgery. Crit Care Med 2005; 33:2082-93
23. Nelson GS, Berger RD, Fetics BJ, Talbot M, Spinelli JC, Hare JM, Kass DA: Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 2000; 102:3053-9
24. Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, Colucci WS, Massie BM, O'Connor CM, Pina I, Quigg R, Silver MA, Gheorghiade M: Short-term intravenous milrinone for acute exacerbation of chronic heart failure: A randomized controlled trial. JAMA 2002; 287:1541-7
25. Felker GM, Benza RL, Chandler AB, Leimberger JD, Cuffe MS, Califf RM, Gheorghiade M, O'Connor CM: Heart failure etiology and response to milrinone in decompensated heart failure: Results from the OPTIME-CHF study. J Am Coll Cardiol 2003; 41:997-1003
26. Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, Cheng ML, Wynne J; ADHERE Scientific Advisory Committee and Investigators; ADHERE Study Group: In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: An analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 2005; 46:57-64
27. Mebazaa A, Parissis J, Porcher R, Gayat E, Nikolaou M, Boas FV, Delgado JF, Follath F: Short-term survival by treatment among patients hospitalized with acute heart failure: The global ALARM-HF registry using propensity scoring methods. Intensive Care Med 2011; 37:290-301
28. Fellahi JL, Parienti JJ, Hanouz JL, Plaud B, Riou B, Ouattara A: Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: Propensity-Adjusted analyses. Anesthesiology 2008; 108:979-87
29. Butterworth J: Dobutamine: Too dangerous for "routine" administration? Anesthesiology 2008; 108:973-4
30. Zangrillo A, Biondi-Zoccai G, Ponschab M, Greco M, Corno L, Covello RD, Cabrini L, Bignami E, Melisurgo G, Landoni G: Milrinone and mortality in adult cardiac surgery: A metaanalysis. J Cardiothorac Vasc Anesth 2012; 26:70-7
31. Leineweber K, Bogedain P, Wolf C, Wagner S, Weber M, Jakob HG, Heusch G, Philipp T, Brodde OE: In patients chronically treated with metoprolol, the demand of inotropic catecholamine support after coronary artery bypass grafting is determined by the Arg389Gly-beta 1-Adrenoceptor polymorphism. Naunyn Schmiedebergs Arch Pharmacol 2007; 375:303-9
32. Parissis JT, Rafouli-Stergiou P, Stasinos V, Psarogiannakopoulos P, Mebazaa A: Inotropes in cardiac patients: Update 2011. Curr Opin Crit Care 2010; 16:432-41